Peptide Hormone News and Research

RSS
Retrophin signs agreement with Novartis for exclusive U.S. license for Syntocinon Nasal Spray

Retrophin signs agreement with Novartis for exclusive U.S. license for Syntocinon Nasal Spray

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

Newer class of diabetes medications may also improve cardiovascular health, researchers report

Newer class of diabetes medications may also improve cardiovascular health, researchers report

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

SanMedica’s SeroVital-hgh could revolutionize both anti-aging and weight-loss industries

SanMedica’s SeroVital-hgh could revolutionize both anti-aging and weight-loss industries

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

NOXXON commences NOX-H94 Phase IIa trial to treat anemia of chronic disease

Combination of hormones may effectively treat obesity with few side effects

Combination of hormones may effectively treat obesity with few side effects

Exendin-4 could effectively treat addiction

Exendin-4 could effectively treat addiction

Scientists identify mechanisms by which GLP-1 protects against kidney disease, diabetes

Scientists identify mechanisms by which GLP-1 protects against kidney disease, diabetes

Researchers use metal complexes to modify peptide hormones

Researchers use metal complexes to modify peptide hormones

New somatostatin vaccines promote weight loss

New somatostatin vaccines promote weight loss

Intensive maternal care during infancy promotes effect of NPY in brain

Intensive maternal care during infancy promotes effect of NPY in brain

Scripps scientist receives Novo Nordisk grant for research into diabetes

Scripps scientist receives Novo Nordisk grant for research into diabetes

Simmons Center to evaluate CGEN-25009 for treatment of idiopathic pulmonary fibrosis

Simmons Center to evaluate CGEN-25009 for treatment of idiopathic pulmonary fibrosis

NOXXON to commence NOX-H94 Phase I trial in anemia of chronic disease

NOXXON to commence NOX-H94 Phase I trial in anemia of chronic disease

Lexicon's second quarter revenues decrease 55% to $0.6 million

Lexicon's second quarter revenues decrease 55% to $0.6 million

Unigene second quarter revenue decreases to $2.5 million

Unigene second quarter revenue decreases to $2.5 million

Unigene accelerates UGP281 anorexigenic peptide to treat obese patients

Unigene accelerates UGP281 anorexigenic peptide to treat obese patients

PROLOR and Yeda enter definitive license agreement for Reversible PEGylation technology

PROLOR and Yeda enter definitive license agreement for Reversible PEGylation technology